• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂是一种多配体交叉β结构受体。

Tissue-type plasminogen activator is a multiligand cross-beta structure receptor.

作者信息

Kranenburg Onno, Bouma Barend, Kroon-Batenburg Loes M J, Reijerkerk Arie, Wu Ya-Ping, Voest Emile E, Gebbink Martijn F B G

机构信息

Department of Medical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.

出版信息

Curr Biol. 2002 Oct 29;12(21):1833-9. doi: 10.1016/s0960-9822(02)01224-1.

DOI:10.1016/s0960-9822(02)01224-1
PMID:12419183
Abstract

Tissue-type plasminogen activator (tPA) regulates fibrin clot lysis by stimulating the conversion of plasminogen into the active protease plasmin. Fibrin is required for efficient tPA-mediated plasmin generation and thereby stimulates its own proteolysis. Several fibrin regions can bind to tPA, but the structural basis for this interaction is unknown. Amyloid beta (Abeta) is a peptide aggregate that is associated with neurotoxicity in brains afflicted with Alzheimer's disease. Like fibrin, it stimulates tPA-mediated plasmin formation. Intermolecular stacking of peptide backbones in beta sheet conformation underlies cross-beta structure in amyloid peptides. We show here that fibrin-derived peptides adopt cross-beta structure and form amyloid fibers. This correlates with tPA binding and stimulation of tPA-mediated plasminogen activation. Prototype amyloid peptides, including Abeta and islet amyloid polypeptide (IAPP) (associated with pancreatic beta cell toxicity in type II diabetes), have no sequence similarity to the fibrin peptides but also bind to tPA and can substitute for fibrin in plasminogen activation by tPA. Moreover, the induction of cross-beta structure in an otherwise globular protein (endostatin) endows it with tPA-activating potential. Our results classify tPA as a multiligand receptor and show that cross-beta structure is the common denominator in tPA binding ligands.

摘要

组织型纤溶酶原激活剂(tPA)通过刺激纤溶酶原转化为活性蛋白酶纤溶酶来调节纤维蛋白凝块的溶解。纤维蛋白是tPA介导的纤溶酶生成所必需的,因此会刺激自身的蛋白水解。纤维蛋白的几个区域可以与tPA结合,但其相互作用的结构基础尚不清楚。β淀粉样蛋白(Aβ)是一种肽聚集体,与患有阿尔茨海默病的大脑中的神经毒性有关。与纤维蛋白一样,它也能刺激tPA介导的纤溶酶形成。β折叠构象中肽主链的分子间堆积是淀粉样肽中交叉β结构的基础。我们在此表明,纤维蛋白衍生肽会形成交叉β结构并形成淀粉样纤维。这与tPA结合以及tPA介导的纤溶酶原激活的刺激相关。包括Aβ和胰岛淀粉样多肽(IAPP)(与II型糖尿病中的胰腺β细胞毒性有关)在内的原型淀粉样肽与纤维蛋白肽没有序列相似性,但也能与tPA结合,并可在tPA介导的纤溶酶原激活中替代纤维蛋白。此外,在原本呈球状的蛋白(内皮抑素)中诱导交叉β结构赋予了它tPA激活潜力。我们的结果将tPA归类为多配体受体,并表明交叉β结构是tPA结合配体的共同特征。

相似文献

1
Tissue-type plasminogen activator is a multiligand cross-beta structure receptor.组织型纤溶酶原激活剂是一种多配体交叉β结构受体。
Curr Biol. 2002 Oct 29;12(21):1833-9. doi: 10.1016/s0960-9822(02)01224-1.
2
Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.衰老和淀粉样β蛋白沉积对阿尔茨海默病Tg2576小鼠模型中纤溶酶原激活剂和纤溶酶原激活剂抑制剂-1的影响。
Brain Res. 2015 Feb 9;1597:159-67. doi: 10.1016/j.brainres.2014.11.042. Epub 2014 Nov 29.
3
Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.Aβ 通过改变纤维蛋白结构和减弱纤溶酶原与纤维蛋白的结合来延迟纤维蛋白凝块的溶解。
Blood. 2012 Apr 5;119(14):3342-51. doi: 10.1182/blood-2011-11-389668. Epub 2012 Jan 11.
4
Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.组织型纤溶酶原激活物结合 RNA 适体抑制 LDL 受体家族介导的内化。
Thromb Haemost. 2015 Jul;114(1):139-49. doi: 10.1160/TH14-08-0686. Epub 2015 Apr 9.
5
The plasmin system is induced by and degrades amyloid-beta aggregates.纤溶酶系统由β淀粉样蛋白聚集体诱导产生并使其降解。
J Neurosci. 2000 Jun 1;20(11):3937-46. doi: 10.1523/JNEUROSCI.20-11-03937.2000.
6
Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.合成B结构域与纤维蛋白原的结合会改变纤维蛋白的特性,并抑制其激活组织纤溶酶原激活物的能力以及被纤溶酶降解的能力。
Biochemistry. 2006 Feb 28;45(8):2657-67. doi: 10.1021/bi0524767.
7
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.锌通过减弱纤溶酶原激活和纤溶酶介导的纤维蛋白降解来延迟血凝块溶解。
Thromb Haemost. 2015 Jun;113(6):1278-88. doi: 10.1160/TH14-09-0771. Epub 2015 Mar 19.
8
Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition.组织型纤溶酶原激活剂需要纤溶酶原调节β淀粉样蛋白的神经毒性和沉积。
J Neurochem. 2000 Nov;75(5):2172-7. doi: 10.1046/j.1471-4159.2000.0752172.x.
9
Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity.β-淀粉样蛋白的纤溶酶裂解:二级结构的改变及对组织纤溶酶原激活物活性的刺激
Biochemistry. 1999 Aug 31;38(35):11570-6. doi: 10.1021/bi990610f.
10
Enhanced fibrinolysis by proteolysed coagulation factor Xa.经蛋白水解的凝血因子Xa增强纤维蛋白溶解作用。
Biochim Biophys Acta. 2010 Apr;1804(4):723-30. doi: 10.1016/j.bbapap.2009.11.011. Epub 2009 Nov 18.

引用本文的文献

1
The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.胰岛组织纤溶酶原激活物/纤溶酶系统在人胰岛淀粉样多肽聚集时上调,并保护β细胞免受聚集诱导的毒性。
Diabetologia. 2024 Sep;67(9):1897-1911. doi: 10.1007/s00125-024-06161-0. Epub 2024 Sep 9.
2
Fibrin-Targeting Immunotherapy for Dementia.纤维蛋白靶向免疫疗法治疗痴呆。
J Prev Alzheimers Dis. 2023;10(4):647-660. doi: 10.14283/jpad.2023.105.
3
Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach.
氨甲环酸在脑淀粉样血管病小鼠模型中的应用:为新型中风治疗方法奠定基础。
Res Pract Thromb Haemost. 2023 Aug 9;7(6):102166. doi: 10.1016/j.rpth.2023.102166. eCollection 2023 Aug.
4
Vascular Dysfunction in Alzheimer's Disease: Alterations in the Plasma Contact and Fibrinolytic Systems.阿尔茨海默病中的血管功能障碍:血浆接触和纤维蛋白溶解系统的改变。
Int J Mol Sci. 2023 Apr 11;24(8):7046. doi: 10.3390/ijms24087046.
5
Viruses and amyloids - a vicious liaison.病毒与淀粉样纤维——一种恶性关联。
Prion. 2023 Dec;17(1):82-104. doi: 10.1080/19336896.2023.2194212.
6
Structural control of fibrin bioactivity by mechanical deformation.机械变形对纤维蛋白生物活性的结构控制。
Proc Natl Acad Sci U S A. 2022 May 31;119(22):e2117675119. doi: 10.1073/pnas.2117675119. Epub 2022 May 25.
7
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.在长新冠/后新冠长期症状中,淀粉样纤维微栓子发挥核心作用:起源和治疗意义。
Biochem J. 2022 Feb 17;479(4):537-559. doi: 10.1042/BCJ20220016.
8
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease.组织型纤溶酶原激活物在中枢神经系统生理学和病理学中的作用:从突触可塑性到阿尔茨海默病。
Semin Thromb Hemost. 2022 Apr;48(3):288-300. doi: 10.1055/s-0041-1740265. Epub 2021 Dec 23.
9
p53, A Victim of the Prion Fashion.p53,朊病毒风尚的受害者。
Cancers (Basel). 2021 Jan 13;13(2):269. doi: 10.3390/cancers13020269.
10
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis.血浆肝细胞生长因子在轻链型和转甲状腺素蛋白型心脏淀粉样变中的诊断及预后价值
JACC CardioOncol. 2020 Mar;2(1):56-66. doi: 10.1016/j.jaccao.2020.01.006. Epub 2020 Mar 17.